HTLV-1 proviral load in infective dermatitis associated with HTLV-1 does not increase after the development of HTLV-1-associated myelopathy/tropical spastic paraparesis and does not decrease after IDH remission
PLoS Negl Trop Dis. 2019 Dec 18;13(12):e0007705. doi: 10.1371/journal.pntd.0007705.…
Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer
J Clin Med. 2019 Dec 11;8(12):2180. doi: 10.3390/jcm8122180.ABSTRACTThe…
Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis
Aliment Pharmacol Ther. 2020 Feb;51(3):374-387. doi: 10.1111/apt.15606.…
Public resources for chemical probes: the journey so far and the road ahead
Future Med Chem. 2021 Apr;13(8):731-747. doi: 10.4155/fmc-2019-0231.…
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
J Clin Oncol. 2020 Feb 10;38(5):395-405. doi: 10.1200/JCO.19.01638.…
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
J Clin Oncol. 2020 Mar 10;38(8):784-792. doi: 10.1200/JCO.19.01231.…
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
Cancer Cell. 2019 Dec 9;36(6):613-629.e7. doi: 10.1016/j.ccell.2019.10.006.…
Corrigendum to ‘Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients’ [Gynecologic Oncology 152 (2019) 270-277]
Gynecol Oncol. 2020 Jan;156(1):262. doi: 10.1016/j.ygyno.2019.10.020.…
Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M
Biomed Pharmacother. 2020 Jan;121:109601. doi: 10.1016/j.biopha.2019.109601.…
Chemokine (C-C motif) ligand 2 and coronary artery disease: Tissue expression of functional and atypical receptors
Cytokine. 2020 Feb;126:154923. doi: 10.1016/j.cyto.2019.154923.…
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
Cancer Res. 2020 Feb 1;80(3):624-638. doi: 10.1158/0008-5472.CAN-19-1840.…
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
NPJ Breast Cancer. 2019 Nov 1;5:38. doi: 10.1038/s41523-019-0127-5.…
